Clinical Trial

A Study to Evaluate the Safety and Effectiveness of Kytogen Defend in Facial Skin Quality Improvement in Adult Participants

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 17, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study was designed to evaluate the efficacy and safety of KIO021, an injectable solution for carboxymethyl chitosan, for temporary improvement of facial skin condition. Designed for forward-looking effectiveness. To achieve this, it is planned that 500 subjects with dry skin and dull complexion on the face will be included in the injection.
Trial Details
NCT Number NCT07179198
Lead Sponsor Sinclair Pharmaceuticals Limited
Conditions Skin Quality
Enrollment 500 participants
Start Date 2025-09-22
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-17